Диссертация (1091718), страница 23
Текст из файла (страница 23)
–V. E63. – P. m1406m1407.152. Книжко, П.О. Вивчення деяких властивостей комплексноï с полукипалладiю зантипiрином (1-фенiл-2,3-диметил-пiразолоном-5) / П.О. Книжко, Г.М. Бублейко, I.В.Чайковська, Л.Н. Вiтульська // Укр. Хим. Ж. – 1971. – Т. 37. – С. 311-313.153.
Mosoarca, E. Recent developments in the coordination chemistry of antipyrine / E. Mosoarca,R. Tudose, L. Sayti, O. Costisor, W. Linert // Rev. Inorg. Chem. – 2008. – V. 28, № 1. – P. 134.154. Wang, Q. Mixed-ligand CoII and CdII complexes with 4-aminoantipyrine / Q. Wang, M.-J. Wu,E.-C. Yang, X.-G. Wang, X.-J. Zhao // J. Coord. Chem. – 2008. – V.
61, № 4. – P. 595-604.155. Mahalingam, V. New Ru(II)–DMSO complexes of ON/SN chelates: Synthesis, behavior ofSchiff bases towards hydrolytic cleavage of C=N bond, electrochemistry and biologicalactivities / V. Mahalingam, N. Chitаpriya, F.R. Fronczek, K. Natarajan // Polyhedron. – 2010. –V. 29. – P.
3363-3371.156. Рукк, Н.С. Некоторые физико-химичесие характеристики антипириновых производныхиодидов лантаноидов / Н.С. Рукк, Л.Д. Исхакова, С.У. Крейнгольд // Коорд. химия. –2002. – Т. 28, № 8. – С. 630-632.157. Santos, P.M.P. Scavenging activity of aminoantipyrines against hydroxyl radical / P.M.P.Santos, A.M.M. Antunes, J. Noronha, E. Fernandes, A.J.S.C. Vieira // Eur. J. Med. Chem.
–2010. – V. 45. – P. 2258-2264.136158. Bashkatova, N.V. Electrochemical, quantum-chemical and antioxidant properties of antipyrineand its derivatives / N.V. Bashkatova, E.I. Korotkova, Yu.A. Karbainov, A.Yu. Yagovkin, A.A.Bakibaev // J. Pharm. Biomed. Anal. – 2005. – V. 37. – P. 1143-1147.159. Costa, D.
Inhibition of human neutrophil oxidative burst by pyrazolone derivatives / D. Costa,A.P. Marques, R.L. Reis, J.L.F.C. Lima, E. Fernandes // Free Radical Bio. Med. – 2006. – V.40. – P. 632-640.160. Rheingold, A.L. Crystal Structures of Three Brilliantly Triboluminescent CentrosymmetricLanthanideComplexes:Hexakis(antipyrine)terbiumPiperidiniumTriiodide,andTetrakis(benzoylacetonato)europate,HexaaquadichloroterbiumChloride/A.L.Rheingold, W.
King // Inorg. Chem. – 1989. – V. 28. – P. 1715-1719.161. Soden, R.R. Effects of Rare-Earth Substitutions on the Fluorescence of Terbium HexaAntipyrine Tri-Iodide / R.R. Soden // J. Аppl. Physics. – 1961. – V. 32. – P. 750-751.162. Clegg, W. Hexakis(antipyrine-O)terbium(III) triiodide at 160 K: confirmation ofcentrosymmetric structure for a brilliantly triboluminescent complex / W. Clegg, G.
Bourhill,I. Sage // Acta Crystallogr. E. – 2002. – V. E58. – P. m159-m161.163. Su, C.-Y. Hexakis(antipyrine-O)terbium(III) triperchlorate / C.-Y. Su, X.-P. Yang, A.-W. Xu,Z.-F. Zhang, H.-K. Liu, B.-S. Kang // Acta Crystallogr. C. – 2000. – V. C56. – P. e82-e83.164. Baker, R.W.
Crystal and Molecular Structure of Hexakisantipyrineyttrium Tri-iodide / R.W.Baker, J.W. Jeffery // J. Chem. Soc. Dalton. –1974. – V. 1. – P. 229-232.165. Рукк, Н.С. Синтез и строение комплексных соединений иодидов лантана, европия искандия с антипирином / Н.С. Рукк, А.С. Анцышкина, Г.Г.
Садиков, В.С. Сергиенко,А.Ю. Скрябина, Р.А. Осипов, Л.Ю. Аликберова // Ж. неорган. химии. – 2009. – Т. 54. – С.1-4.166. Садиков, Г.Г. Строение комплекса йодида скандия с антипирином (АП) и сопоставлениеего с неизоструктурными аналогами – соединениями [Ln(АП)6]I3 (Ln = La, Y, Eu) / Г.Г.Садиков, А.С. Анцышкина, В.С. Сергиенко // Кристаллография. – 2009.
– Т. 54, № 5. – С.887-891.167. Абдуллин, Б.Ф. Рентгенографическое исследование комплексных соединений нитратовРЗЭ с производными пиразолона / Б.Ф. Абдуллин, Г.Г. Садиков, М.Г. Лутфуллина, Т.А.Маликова, М.А. Порай-Кошиц // Кристаллография. – 1980. – Т. 25. – С. 397-399.168. Yang, X.-P. Syntheses, Crystal Structures, and Luminescent Properties of LanthanideComplexes with Tripodal Ligands Bearing Benzimidazole and Pyridine Groups / X.-P. Yang,B.-S. Kang, W.-K.
Wong, C.-Y. Su, H.-Q. Liu // Inorg. Chem. – 2003. – V. 42. – P. 169-179.137169. Joseph, S. Yttrium and lanthanide perchlorate complexes of 4-formyl-2,3-dimethyl-1-phenyl-3pyrazoline-5-one / S. Joseph, М.К.М. Nair, P.K. Radhakrishnan // Synth. React. Inorg. Met.-Org.Chem. – 1997. – V. 27. – Р. 1025-1038.170. Joseph, S. Rare earth iodide complexes of 4-formyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one / S.Joseph, P.K.
Radhakrishnan // Synth. React. Inorg. Met.-Org. Chem. – 1999. – V. 29. – Р. 12191229.171. Thomas, M. Rare-earth iodide complexes of 4-(2’,4’-dihydroxyphenylazo)antipyrine / M.Thomas, M.K.N. Nair, P. K. Radhakrishan // Synth. React. Inorg. Met.-Org. Chem. – 1995. –V. 25. – Р. 471-479.172. Ajithkumar,G.Yttriumandlanthanidenitratecomplexesof2,3-dimethyl-4-formyl(benzhydrazide)-1-phenyl-3-pyrazoline-5-one / G. Ajithkumar, P.K. Radhakrishnan // Synth.React. Inorg. Met.-Org.
Chem. – 2002. – V. 32. – Р. 831-842.173. Joseph,M.Complexesofyttriumandlanthanidebromideswith4-N-(2'-hydroxybenzylidene)aminoantipyrine / M. Joseph, M.K.M. Nair, P.K. Radhakrishan // Synth.React. Inorg. Met.-Org. Chem. – 1995. – V. 25. – Р. 1331-1334.174. Joseph,S.YttirumandlanthanideiodidecomplexesofN,N`-bis(4-antipyrylmethyliden)ethylenediamine / S. Joseph, P.K. Radhakrishnan // Polyhedron. – 1999. –V. 18. – P. 1881-1884.175.
Joseph,S.YttriumandlanthanideperchloratecomplexesofN,N'-bis(4-antipyrylmethylidene)ethylenediamine / S. Joseph, P.K. Radhakrishnan // Synth. React. Inorg. Met.Org. Chem. – 1998. – V. 28. – Р. 423-435.176. Nair, М.К.М. Synthesis and characterization of iodide complexes of yttrium and lanthanides with1,2-(diimino-4’-antipyrinyl)ethane / М.К.М.
Nair, P.K. Radhakrishnan // Synth. React. Inorg.Met.-Org. Chem. – 1995. – V. 25. – Р. 1077-1089.177. International Agency for Reseach on Cancer, World Health Organization, Press Release 223,12 December 2013. URL: http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf (датаобращения: 31.01.2014).178. Zhang, J. Research progress on drugs of rare earth complexes / J. Zhang, M. Yang // Chinese J.Rare Metal.
– 2005. – V. 29. – P. 918-926.179. Boer, D.R. DNA-binding drugs caught in action: the latest 3D pictures of drug-DNAcomplexes / D.R. Boer, A. Canals, M. Coll // J. Chem. Soc. Dalton. – 2009. – P. 399-414.180. Wang, B.D. Synthesis, crystal structure and DNA-binding studies of the Ln(III) complex with6-hydroxychromone-3-carbaldehyde benzoyl hydrazone / B.D. Wang, Z.Y.
Yang, P. Crewdson,D.Q. Wang // J. Inorg. Biochem. – 2007. – V. 101. – Р. 1492-1504.138181. Khorasani-Motlagh, M. Fluorescenceand DNA-binding properties of neodymium(III) andpraseodymium(III) complexes containing 1,10-phenanthroline / M. Khorasani-Motlagh, M.Noroozifar, S. Mirkazehi-Rigi // Spectrochim. Acta A: Mol. Biomol. Spectrosc. – 2011.
– V. 79.– P. 978-984.182. Lown, J.W. Molecular mechanisms of action of anticancer agents involving free radicalintermediates / J.W. Lown // Adv. Free Radical Biol. – 1985. – V. 1. – P. 225-264.183. Zhang, L.-W. Study of the interactions between fluoroquinolones and human serum albuminby affinity capillary electrophoresis and fluorescence method / L.-W. Zhang, K. Wang, X.-X.Zhang // Anal. Chim. Acta. – 2007.
– V. 603. – P. 101-110.184. Vyas, K.M. Acyl pyrazolones and their structural analogues: Synthesis, characterization,crystal structure and studies on their bio-active metal complexes / K.M. Vyas. – Thesissubmitted for the degree of PhD. The Maharaja Sayajirao University of Baroda, Valodara, India,2012. – 288 p.185. Alama, A.
Organometallic compounds in oncology: implications of novel organotins asantitumor agents / A. Alama, B. Tasso, F. Novelli, F. Sparatore // Drug discov.today. – 2009. –V. 14. – P. 500-508.186. Wang, X. Towards the rational design of platinum(II) and gold(III) complexes as antitumoragents / X. Wang, Z. Guo // J. Chem. Soc. Dalton. – 2008.
– P. 1521-1532.187. Yamase, T. Medical Chemistry of Polyoxometalates. Part 1. Potent Antitumor Activity ofPolyoxomolybdates on Animal Transplantable Tumors and Human Cancer Xenograft / T.Yamase, H. Fujita, K. Fukushima // Inorg. Chim. Acta. – 1988. – V. 158. – P. 15-18.188. Bruijnincx, P.C.A. New trends for metal complexes with anticancer activity / P.C.A.Bruijnincx, P.J. Sadler // Curr. Opin. Chem. Biol. – 2008. – V.
12. – P. 197-206.189. Li, Y. Synthesis, Characterization, DNA Binding Properties and Antioxidant Activity ofLn(III) Complexes with Schiff Base Ligand Derived from 3-Carbaldehyde Chromone andAminophenazone / Y. Li, Z. Yang, T. Li, Z. Liu, B. Wang // J. Fluoresc. – 2011. – V. 21.
– P.1091-1102.190. Redling, K. Rare earth elements in agriculture with emphasis on animal husbandry / K.Redling. – Dissertation. LMU München: Faculty of Veterinary Medicine, München, Germany,2006. – 326 p.191. Franklin, S.J. Lanthanide-mediated DNA hydrolysis / S.J. Franklin // Curr. Opin. Chem. Biol.– 2001. – V. 5. – P. 201-208.192. Heffeter,P.Anticanceractivityofthelanthanumcompound[tris(1,10-henanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24) / P.
Heffeter, M.A. Jakupec, W.139Körner, S. Wild, N.G. Keyserlingk, L. Elbling, H. Zorbas, A. Korynevska, S. Knasmüller, H.Sutterlüty, M. Micksche, B.K. Keppler, W. Berger // Biochem. Pharmacol. – 2006. – V. 71. – P.426-440.193. Heffeter, P. Multidrug-resistant cancer cells are preferential targets of the new antineoplasticlanthanum compound KP772 (FFC24) / P. Heffeter, M.A. Jakupec, W. Körner, P. Chiba, C.Pirker, R. Dornetshuber, L. Elbling, H.
Sutterlüty, M. Micksche, B.K. Keppler, W. Berger //Biochem. Pharmacol. – 2007– V. 73 – Р. 1873-1886.194. Barta, C.A. Lanthanide containing compounds for therapeutic care in bone resorption disorders/ C.A. Barta, K. Sachs-Barrable, J. Jia, K.H. Thompson, K.M. Wasan, C. Orvig // J. Chem. Soc.Dalton. –2007. – V. 43. – P. 5019-5030.195. Chen, Z.F. Synthesis, characterization and preliminary cytotoxicity evaluation of fivelanthanide(III)-plumbagin complexes / Z.F. Chen, M.X. Tan, Y.-C.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
